Agile Therapeutics Announces Proposed Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall Street ends down sharply; worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Vertiv shares fall on analyst downgrades and options bets
- Stocks slip as dollar heads for weekly loss
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
Agile Therapeutics (AGRX) Prices 5.5M Common Stock Offering at $6.35/Share
January 22, 2016 9:22 AM ESTAgile Therapeutics, Inc. (Nasdaq: AGRX) announced the pricing of its underwritten public offering of 5,511,812 shares of its common stock at a public offering price of $6.35 per share. The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Agile Therapeutics, are expected to be approximately $35 million. In addition,... More



